Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
A Phase 3, Randomized, Double-blind, Placebo-controlled, Cross over Study of Oral Deucrictibant Soft Capsule for On Demand Treatment of Attacks in Adolescents and Adults with Hereditary Angioedema	Pharvaris Netherlands B.V.	Ongoing	Deucrictibant	3	PHA022121-C306	King Faisal Specialist Hospital and Research Center (Riyadh)
A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)	Janssen Research & Development	Ongoing	Nipocalimab	3	80202135EBF3001	King Faisal Specialist Hospital and Research Center (Riyadh), King Saud Medical City (Riyadh), King Fahad University Hospital (Al-Khobar)
Evaluating the efficacy and safety of Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine) in Newly Diagnosed Advanced Hodgkin Lymphoma Early Interim PET-Positive Patients; A Multi-Center, Open Label, Single Arm, Phase II, PET-Adaptive Study	King Abdullah International Medical Research Center’s (KAIMRC)	Ongoing	Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine	2	RJ19/119/J	King Abdullah Medical Complex (Jeddah)
A Randomized Controlled Trial Comparing Blood Glucose Control Intraoperative Between Insulin Drip vs. Insulin Boluses	King Faisal Specialist Hospital and Research Center (Jeddah)	Ongoing	Insulin	3	2023-45	King Faisal Specialist Hospital and Research Center (Jeddah)
The ENERGY 3 Study: A Randomized, Controlled, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of INZ-701 in Children with Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency	Inozyme Pharma, Inc	Ongoing	INZ701	3	INZ701-106	King Faisal Specialist Hospital and Research Center (Riyadh)
Long-term pain and adherence observational study for Endometriosis treatment	Abbott	Ongoing	Duphaston	4	DYDR-522-0318	Dr.Arab Clinic
Real world Assessment of Dyslipidemia patients on Inclisiran effiCacy And toLerability: The RADICAL Study	Novartis	Ongoing	LEQVIO	4	CKJX839A1S	Dallah Hospital (Riyadh),International Medical Center (Jeddah), Armed Force Hospital (Tabuk) , My Clinic (Jeddah) Mouwasat Hospital (Dammam)
Effect of celecoxib on postoperative narcotic use and disease severity in patients with aspirin-exacerbated respiratory disease and chronic rhinosinusitis: a randomized controlled trial	King Khalid University Hospital	Ongoing	Celecoxib	4	114809	King Khalid University Hospital (Riyadh) King Abdulaziz University Hospital (Riyadh)
EASi-HF - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral BI 690517 and empagliflozin compared with placebo and empagliflozin in participants with symptomatic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) >40%	Boehringer Ingelheim	Ongoing	BI 690517 , empagliflozin	3	1378-0020	1-King Fahad Medical City (Riyadh) 2-King Khalid University Hospital (Riyadh) 3-King Faisal Specialist Hospital and Research Center (Riyadh) 4-King Abdulaziz Medical City NG (Riyadh) 5-King Abdulaziz University Hospital (Jeddah)
Effect of Probiotics “Psychobiotics” on Depression in Adults with Obesity and Metabolic Syndrome in Riyadh City	King Khalid University Hospital	Ongoing	Winclove’s Ecologic® Barrier probiotics	3	E-23-7867	King Khalid University Hospital (Riyadh)